(ACTION) Adoptive Cellular Therapy following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas

Purpose

It is believed that the body's immune system protects the body by attacking and killing tumor cells. T-lymphocytes (T-cells) are part of the immune system and can attack when they recognize special proteins on the surface of tumors. In most patients with advanced cancer, T-cells are not stimulated enough to kill the tumor.

In this research study, we will use a patient's tumor to make a vaccine which we hope will stimulate T-cells to kill tumor cells and leave normal cells alone.

Eligibility

  • 3 - 21 years old
  • Patients with histologically confirmed WHO Grade III or IV malignant glioma
  • Scheduled for definitive surgical resection of suspected HGG (biopsy only subjects are not eligible for this study)
For additional information about eligibility criteria, please contact the study coordinator Marcia Hodik: 

Procedures 

  • Drug: Temozolomide
  • Drug type: Chemotherapy

Full details regarding study procedures can be explained by the study coordinator Marcia Hodik: 

Age

N/A

Gender

Male
Female

Can be done from home

No

Keywords

Brain Tumors, Pediatric Brain Tumors, Brain Tumor, Brain tumor - children, Glioma

Principal Investigator

Elias Sayour, MD, PhD

Department

Neurosurgery

Contact Information

marcia.hodik@neurosurgery.ufl.edu

352.273.6971


Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams